The Washington Post: GreenLight plans to launch a clinical trial in Africa next year

The Washington Post reports on GreenLight Biosciences’ plans to launch a clinical trial in Africa next year.

The Washington Post reports on vaccines in Africa and mentions GreenLight Bioscience’s plans to launch a clinical trial in Africa next year. An extract is below:

GreenLight Biosciences, a start-up company that has been making RNA for agricultural applications, is working toward making mRNA vaccines with a different manufacturing process that could be easier to scale up. GreenLight plans to launch a clinical trial in Africa next year.

Read the full article here.

Find out more about how GreenLight manufactures RNA here.